Msn Pharmachem Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MONTELUKAST SODIUM USP [ROUTE CODE - "MB"], with a corresponding US DMF Number 22484.
Remarkably, this DMF maintains an Active status since its submission on February 05, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 22, 2014, and payment made on November 12, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II